Endogenous CGRP protects against neointimal hyperplasia following wire-induced vascular injury

Journal of Molecular and Cellular Cardiology

Volumn 59, Issue , 2013, Pages 55-66

  Yang, Lei ^a,b   Sakurai, Takayuki ^a   Kamiyoshi, Akiko ^a   Ichikawa Shindo, Yuka ^a   Kawate, Hisaka ^a   Yoshizawa, Takahiro ^a,c   Koyama, Teruhide ^a,c   Iesato, Yasuhiro ^a   Uetake, Ryuichi ^a   Yamauchi, Akihiro ^a   Tanaka, Megumu ^a   Toriyama, Yuichi ^a   Igarashi, Kyoko ^a   Shindo, Takayuki ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

Calcitonin gene related peptide (CGRP); Inflammation; Neointimal hyperplasia; Oxidative stress; Vascular smooth muscle cell (VSMC)

Indexed keywords

4 HYDROXYNONENAL; CALCITONIN GENE RELATED PEPTIDE; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE SYNTHASE; PROTEIN P47PHOX; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL INJURY; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR DISEASE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; ENZYME INHIBITION; IN VITRO STUDY; KNOCKOUT MOUSE; MACROPHAGE; MALE; MIGRATION INHIBITION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTECTION; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE CELL; WILD TYPE MOUSE; ANIMAL; CELL MOTION; CYTOLOGY; GENETICS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CELL MOVEMENT; CELL PROLIFERATION; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OXIDATIVE STRESS; VASCULAR SYSTEM INJURIES;

EID: 84874941778     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.02.002     Document Type: Article

References (51)

1. Costa, M.A., Simon, D.I., Molecular basis of restenosis and drug-eluting stents. Circulation 111 (2005), 2257–2273.
2. Welt, F.G., Rogers, C., Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 22 (2002), 1769–1776.
3. Ross, R., Atherosclerosis—an inflammatory disease. N Engl J Med 340 (1999), 115–126.
4. Marx, S.O., Totary-Jain, H., Marks, A.R., Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv 4 (2011), 104–111.
5. Dzau, V.J., Braun-Dullaeus, R.C., Sedding, D.G., Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 8 (2002), 1249–1256.
6. Wu, L., Iwai, M., Nakagami, H., Li, Z., Chen, R., Suzuki, J., et al. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 104 (2001), 2716–2721.
7. Duckers, H.J., Boehm, M., True, A.L., Yet, S.F., San, H., Park, J.L., et al. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7 (2001), 693–698.
8. Shi, Y., Niculescu, R., Wang, D., Patel, S., Davenpeck, K.L., Zalewski, A., Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler Thromb Vasc Biol 21 (2001), 739–745.
9. Patterson, C., Ruef, J., Madamanchi, N.R., Barry-Lane, P., Hu, Z., Horaist, C., et al. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo. J Biol Chem 274 (1999), 19814–19822.
10. Rosenfeld, M.G., Mermod, J.J., Amara, S.G., Swanson, L.W., Sawchenko, P.E., Rivier, J., et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304 (1983), 129–135.
11. Holzer, P., Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24 (1988), 739–768.
12. Wimalawansa, S.J., Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev 17 (1996), 533–585.
13. Deng, P.Y., Li, Y.J., Calcitonin gene-related peptide and hypertension. Peptides 26 (2005), 1676–1685.
14. Li, X.W., Hu, C.P., Wu, W.H., Zhang, W.F., Zou, X.Z., Li, Y.J., Inhibitory effect of calcitonin gene-related peptide on hypoxia-induced rat pulmonary artery smooth muscle cells proliferation: role of ERK1/2 and p27. Eur J Pharmacol 679 (2012), 117–126.
15. Chattergoon, N.N., D'Souza, F.M., Deng, W., Chen, H., Hyman, A.L., Kadowitz, P.J., et al. Antiproliferative effects of calcitonin gene-related peptide in aortic and pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 288 (2005), L202–L211.
16. Thievent, A., Sena, S., Parlakian, A., Breuzard, G., Beley, A., Rochette, L., et al. Potential role of the neuropeptide CGRP in the induction of differentiation of rat hepatic portal vein wall. Peptides 26 (2005), 1567–1572.
17. Supowit, S.C., Rao, A., Bowers, M.C., Zhao, H., Fink, G., Steficek, B., et al. Calcitonin gene-related peptide protects against hypertension-induced heart and kidney damage. Hypertension 45 (2005), 109–114.
18. Yoneda, M., Sato, Y., Nakamura, K., Yokohama, S., Kono, T., Watanobe, H., et al. Involvement of calcitonin gene-related peptide and capsaicin-sensitive afferents in central thyrotropin-releasing hormone-induced hepatic cytoprotection. Eur J Pharmacol 478 (2003), 173–177.
19. Bennett, G.S., Garrett, N.E., Diemel, L.T., Brain, S.D., Tomlinson, D.R., Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor. Br J Pharmacol 124 (1998), 1573–1579.
20. Bunker, C.B., Reavley, C., O'Shaughnessy, D.J., Dowd, P.M., Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon. Lancet 342 (1993), 80–83.
21. Kawai, J., Ando, K., Tojo, A., Shimosawa, T., Takahashi, K., Onozato, M.L., et al. Endogenous adrenomedullin protects against vascular response to injury in mice. Circulation 109 (2004), 1147–1153.
22. Kohno, M., Yasunari, K., Minami, M., Kano, H., Maeda, K., Mandal, A.K., et al. Regulation of rat mesangial cell migration by platelet-derived growth factor, angiotensin II, and adrenomedullin. J Am Soc Nephrol 10 (1999), 2495–2502.
23. Qin, X.P., Ye, F., Hu, C.P., Liao, D.F., Deng, H.W., Li, Y.J., Effect of calcitonin gene-related peptide on angiotensin II-induced proliferation of rat vascular smooth muscle cells. Eur J Pharmacol 488 (2004), 45–49.
24. Sata, M., Saiura, A., Kunisato, A., Tojo, A., Okada, S., Tokuhisa, T., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8 (2002), 403–409.
25. Oh-hashi, Y., Shindo, T., Kurihara, Y., Imai, T., Wang, Y., Morita, H., et al. Elevated sympathetic nervous activity in mice deficient in alphaCGRP. Circ Res 89 (2001), 983–990.
26. Sata, M., Maejima, Y., Adachi, F., Fukino, K., Saiura, A., Sugiura, S., et al. A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol 32 (2000), 2097–2104.
27. Yoshioka, T., Takahashi, M., Shiba, Y., Suzuki, C., Morimoto, H., Izawa, A., et al. Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc Res 70 (2006), 61–69.
28. Kobayashi, M., Inoue, K., Warabi, E., Minami, T., Kodama, T., A simple method of isolating mouse aortic endothelial cells. J Atheroscler Thromb 12 (2005), 138–142.
29. Ray, J.L., Leach, R., Herbert, J.M., Benson, M., Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci 23 (2001), 185–188.
30. Hirata, Y., Takagi, Y., Takata, S., Fukuda, Y., Yoshimi, H., Fujita, T., Calcitonin gene-related peptide receptor in cultured vascular smooth muscle and endothelial cells. Biochem Biophys Res Commun 151 (1988), 1113–1121.
31. Tanaka, K., Sata, M., Hirata, Y., Nagai, R., Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res 93 (2003), 783–790.
32. Sueur, S., Pesant, M., Rochette, L., Connat, J.L., Antiapoptotic effect of calcitonin gene-related peptide on oxidative stress-induced injury in H9c2 cardiomyocytes via the RAMP1/CRLR complex. J Mol Cell Cardiol 39 (2005), 955–963.
33. Kamiyoshi, A., Sakurai, T., Ichikawa-Shindo, Y., Fukuchi, J., Kawate, H., Muto, S., et al. Endogenous alphaCGRP protects against concanavalin A-induced hepatitis in mice. Biochem Biophys Res Commun 343 (2006), 152–158.
34. Li, W., Wang, T., Ma, C., Xiong, T., Zhu, Y., Wang, X., Calcitonin gene-related peptide inhibits interleukin-1beta-induced endogenous monocyte chemoattractant protein-1 secretion in type II alveolar epithelial cells. Am J Physiol Cell Physiol 291 (2006), C456–C465.
35. Schneider, L., Hartwig, W., Flemming, T., Hackert, T., Fortunato, F., Heck, M., et al. Protective effects and anti-inflammatory pathways of exogenous calcitonin gene-related peptide in severe necrotizing pancreatitis. Pancreatology 9 (2009), 662–669.
36. Zhang, X., Zhuang, J., Wu, H., Chen, Z., Su, J., Chen, S., et al. Inhibitory effects of calcitonin gene-related peptides on experimental vein graft disease. Ann Thorac Surg 90 (2010), 117–123.
37. Yajima, N., Takahashi, M., Morimoto, H., Shiba, Y., Takahashi, Y., Masumoto, J., et al. Critical role of bone marrow apoptosis-associated speck-like protein, an inflammasome adaptor molecule, in neointimal formation after vascular injury in mice. Circulation 117 (2008), 3079–3087.
38. Koundrioukoff, S., Jonsson, Z.O., Hasan, S., de Jong, R.N., van der Vliet, P.C., Hottiger, M.O., et al. A direct interaction between proliferating cell nuclear antigen (PCNA) and Cdk2 targets PCNA-interacting proteins for phosphorylation. J Biol Chem 275 (2000), 22882–22887.
39. Das, M., Bouchey, D.M., Moore, M.J., Hopkins, D.C., Nemenoff, R.A., Stenmark, K.R., Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on g protein-mediated activation of mitogen-activated protein kinases. J Biol Chem 276 (2001), 15631–15640.
40. Touyz, R.M., Deng, L.Y., He, G., Wu, X.H., Schiffrin, E.L., Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases. J Hypertens 17 (1999), 907–916.
41. Schramm, A., Matusik, P., Osmenda, G., Guzik, T.J., Targeting NADPH oxidases in vascular pharmacology. Vascul Pharmacol 56 (2012), 216–231.
42. Brain, S.D., Grant, A.D., Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84 (2004), 903–934.
43. Zheng, S., Li, W., Xu, M., Bai, X., Zhou, Z., Han, J., et al. Calcitonin gene-related peptide promotes angiogenesis via AMP-activated protein kinase. Am J Physiol Cell Physiol 299 (2010), C1485–C1492.
44. Gray, D.W., Marshall, I., Nitric oxide synthesis inhibitors attenuate calcitonin gene-related peptide endothelium-dependent vasorelaxation in rat aorta. Eur J Pharmacol 212 (1992), 37–42.
45. Wisskirchen, F.M., Burt, R.P., Marshall, I., Pharmacological characterization of CGRP receptors mediating relaxation of the rat pulmonary artery and inhibition of twitch responses of the rat vas deferens. Br J Pharmacol 123 (1998), 1673–1683.
46. Saito, A., Masaki, T., Uchiyama, Y., Lee, T.J., Goto, K., Calcitonin gene-related peptide and vasodilator nerves in large cerebral arteries of cats. J Pharmacol Exp Ther 248 (1989), 455–462.
47. Wellman, G.C., Quayle, J.M., Standen, N.B., ATP-sensitive K + channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle. J Physiol 507:Pt 1 (1998), 117–129.
48. Bol, M., Leybaert, L., Vanheel, B., Influence of methanandamide and CGRP on potassium currents in smooth muscle cells of small mesenteric arteries. Pflugers Arch 463 (2012), 669–677.
49. Zhou, Z., Hu, C.P., Wang, C.J., Li, T.T., Peng, J., Li, Y.J., Calcitonin gene-related peptide inhibits angiotensin II-induced endothelial progenitor cells senescence through up-regulation of klotho expression. Atherosclerosis 213 (2010), 92–101.
50. Kong, D., Melo, L.G., Gnecchi, M., Zhang, L., Mostoslavsky, G., Liew, C.C., et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 110 (2004), 2039–2046.
51. Gulati, R., Jevremovic, D., Peterson, T.E., Witt, T.A., Kleppe, L.S., Mueske, C.S., et al. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation 108 (2003), 1520–1526.